Filing Details
- Accession Number:
- 0001104659-20-081190
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-06 16:00:55
- Reporting Period:
- 2020-07-01
- Accepted Time:
- 2020-07-06 16:00:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1556263 | Syros Pharmaceuticals Inc. | SYRS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1253170 | Srinivas Akkaraju | C/O Syros Pharmaceuticals, Inc. 620 Memorial Drive, Suite 300 Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-07-01 | 4,627 | $11.01 | 1,433,943 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.
- These sales were executed in multiple trades at prices ranging from $11.00 to $11.09. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide full information regarding the number of shares and prices at which these sales were effected, upon request, to the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer.
- Securities held by Samsara BioCapital, L.P. ("Samsara BioCapital"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara BioCapital. The Reporting Person disclaims beneficial ownership of these securities except to the extent of the Reporting Person's pecuniary interest therein.
Billionaire Hedge Funds
